IRB Study Number 25-1033
Status Recruiting
Phase Not Applicable
Location U Building - Mellen Center
Institute Neurological Institute
Description
The purpose of this study is to measure the ability and effectiveness of neuroperformance with passive or minimally interactive technology in patients with neurological diseases. Neuroperformance uses digital, automated tools to assess neurological function, with the goal of improving different aspects of care.
There is 1 in-clinic visit taking around 1 hour, with some noninvasive assessments.
Inclusion Criteria
- Age 18-80 years
- Established multiple sclerosis, Parkinson's disease, Alzheimer's disease, or healthy control
- Ability to walk with or without assistive device
Exclusion Criteria
- Recent injury or illness that would confound measurements
